Shin Nippon Biomedical Laboratories (SNBL)
Shin Nippon Biomedical Laboratories (SNBL), was founded in Kagoshima as Japan’s first contract research organization in 1957.
Market cap
$456m
Enterprise value
$628m
Share price
JPY1413.00 2395.T
- Healthcare
- biotechnology
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
No items found
No investors found
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 4 % | 17 % | 41 % | 5 % | 23 % | 7 % | 11 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 33 % | 49 % | 44 % | 34 % | 29 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 24 % | 40 % | 24 % | 21 % | 15 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 3 % | 2 % | 3 % | 7 % | 7 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Shin Nippon Biomedical Laboratories (SNBL)
Edit
exited
ACQUISITION by Shin Nippon Biomedical Laboratories (SNBL) Apr 2023
ACQUISITION by iPS PORTAL Sep 2014
exited